Trials In Focus

June 21, 2010

Inside Stories – Asian trial growth creates hurdles

Despite rapid growth in clinical trial activity across Asia, sponsors and CROs need to take care in managing unfamiliar environments says the CEO of Australian-based CRO, Novotech.

Alek Safarian told the 46th annual meeting of the Drug Information Association (DIA) in Washington DC last week that regulatory complexity means the number of trials, the number of patients in trials, and the length of trials is growing fast. The average length of a clinical trial increased by almost 70% between 1999 and 2006, Mr Safarian said. By Simone du Toit

Other relevant content